[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Filters

Search
Categories
39,697
6,143
957
31
48
3,435
Publishers
1,678
1,678
250
37
2,909
47
292
33
52
363
220
4
5
1
180
15
78
6
63
8
9
73
2
14
3
3
46
13
621
1
3
1
1,551
12
122
579
11
7
5,320
18
5
31
54
383
1,425
40
34
11
37
46
326
43
50
1,239
40
26
7
6
2
4
17
15
877
3,353
2,223
11
22
1
13
30
229
2
7
10
4
44
3
18
28
1
5
6
2
2
32
2
13
56
19
1
11
35
105
1
14
2
125
172
15,659
6
4
2
1
4
5
13
4
9
1
47
11
4,835
14
49
1
23
15
1
2
1
42
502
118
54
55
14
18
2
221
567
2
1
2
5
88
60
60
34
42
22
2
14
5
23
2
Regions
37
10
7
5
3
5,162
1,988
246
174
125
116
97
82
82
74
58
57
55
52
47
45
44
38
33
33
33
32
32
32
31
31
31
29
27
26
26
24
24
24
24
24
22
21
21
21
20
20
20
18
17
16
14
13
11
11
10
5
17
5
9
5
33
7
7
10
3,992
201
30
27
85
78
30
27
12
11
8
7
5
1
7
6
6
4
5
5
5
1
1
1
2
2
2,746
8
5
1
1
16
16
64
6
61
9
Price
Date
Pages
Offers
1
5
1
2
566

Pharmaceuticals Market Research Reports & Industry Analysis

Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.

The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.

The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.

Publications found: 50,311
Sort by:
EIS Eczacibasi Ilaç Sanayi ve Ticaret A.S. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

EIS Eczacibasi Ilaç Sanayi ve Ticaret A.S. engages in the production, marketing, and sale of pharmaceutical, veterinary, and health care products primarily in Turkey. It also procures and sells person...

January 2020 50 pages
ALK-Abelló A/S Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

ALK-Abello A/S, a pharmaceutical company, engages in the development and sale of products for the diagnosis, prevention, and treatment of allergies. The company offers GRAZAX, an allergy vaccination t...

January 2020 50 pages
Advanced Viral Research Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Advanced Viral Research Corp., a biopharmaceutical company, focuses on the discovery, development and commercialization of small molecule therapeutics that address medical needs for various degenerati...

January 2020 50 pages
Advanced Proteome Therapeutics Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Advanced Proteome Therapeutics Corporation, a development stage biotechnology company, through its subsidiary, Advanced Proteome Therapeutics, Inc., focuses on the development and commercialization of...

January 2020 50 pages
Advanced Life Sciences Holdings, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs in the areas of infectious disease, oncology, and respiratory...

January 2020 50 pages
Advanced Cell Technology Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Advanced Cell Technology, Inc., a biotechnology company, engages in the development and commercialization of human embryonic and adult stem cell technology in the field of regenerative medicine. Opera...

January 2020 50 pages
Adolor Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Adolor Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of prescription pain management products. ENTEREG (alvimopan) The company's primary produc...

January 2020 50 pages
Adimmune Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Adimmune Corporation engages in the development, manufacture, and distribution of human vaccines in Taiwan. It offers vaccines, diagnostics, and biological products. The company’s primary products inc...

January 2020 50 pages
Adherex Technologies Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Adherex Technologies Inc. operates as a development stage biopharmaceutical company with a portfolio of product candidates under development for use in the treatment of cancer. Products The company ha...

January 2020 50 pages
Adeona Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Adeona Pharmaceuticals, Inc., a pharmaceutical company, develops medicines for serious central nervous systems diseases. Product Candidates Trimesta: Trimesta (estriol) is an investigational oral drug...

January 2020 50 pages
Addex Pharmaceuticals Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Addex Pharmaceuticals Ltd. focuses on the discovery, development, and commercialization of small molecule pharmaceutical products for the treatment of human health. Its product candidates include ADX4...

January 2020 50 pages
Adcock Ingram Holdings Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Adcock Ingram Holdings Limited manufactures and sells prescription, generic, and OTC products. It offers a portfolio of branded and generic medicines in various therapeutic categories, including aller...

January 2020 50 pages
Adamis Pharmaceuticals Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Adamis Pharmaceuticals Corporation, a specialty pharmaceutical company, develops patented vaccine technology to provide protection against various viral infectious agents. The company primarily offers...

January 2020 50 pages
Acuvax Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Acuvax Limited engages in the research and development of cancer therapies and vaccines in Australia and North America. The company’s main business activities include a 28% ownership in Hawaii Biotech...

January 2020 50 pages
Acusphere Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Acusphere, Inc., a specialty pharmaceutical company, develops drugs and improved formulations of existing drugs using its proprietary microparticle technology. The company's main product, Imagify (per...

January 2020 50 pages
Acura Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and manufacture of product candidates providing abuse deterrent features and benefits utilizing i...

January 2020 50 pages
ActiveCare, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

ActiveCare, Inc. manufactures and sells medical diagnostic equipment, and laboratory stains and solutions. Product The company's primary product is ActiveOne device, which is a patented mobile persona...

January 2020 50 pages
Active Biotech AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Active Biotech AB, a biotechnology company, focuses on the research and development of drugs for the treatment of cancer and autoimmune/inflammatory diseases. Its projects in clinical development incl...

January 2020 50 pages
Actinogen Limited. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Actinogen Limited operates as a biotechnology company in Australia. The company specializes in the detection and isolation of soil actinomycetes that are found in Western Australia, and the semi-purif...

January 2020 50 pages
Actelion Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Actelion, Ltd., a biopharmaceutical company, engages in the discovery, development and commercialization of treatments to serve high unmet medical needs. The company operates primarily in Switzerland,...

January 2020 50 pages
Acrux Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Acrux Limited, a drug delivery company, engages in developing and commercializing a range of patient-preferred, patented pharmaceutical products for global markets, using its technology to administer...

January 2020 50 pages
Acron Genomics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Acrongenomics, Inc., a development stage company, focuses on the research and development in the field of life science, including BioLED technology, which combines microfluidics and polymer Light Emit...

January 2020 50 pages
Acorda Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Acorda Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in the identification, development, and commercialization of therapies that improve neurological function in people wit...

January 2020 50 pages
Acino Holding AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Acino Holding Ltd., together with its subsidiaries, engages in the development, registration, and manufacture of generic and patent-protected pharmaceuticals using drug delivery technologies. It provi...

January 2020 50 pages
Achillion Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Achillion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of innovative treatments for infectious diseases. Drug Candidate Pipeline The...

January 2020 50 pages
Access Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Access Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing a range of pharmaceutical products primarily based upon its nanopolymer chemistry technologies and other drug delivery...

January 2020 50 pages
Accentia Biopharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Accentia Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of late-stage, targeted therapeutic clinical products. The company has three products i...

January 2020 50 pages
Accelrys Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Accelrys, Inc. engages in the development and commercialize of scientific business intelligence software and solutions that enable its customers to accelerate the discovery and development of drugs an...

January 2020 50 pages
Accelr8 Technology Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Accelr8 Technology Corporation focuses on the development and commercialization of an integrated system to identify bacteria and their mechanisms of antibiotic resistance in critically ill patients. P...

January 2020 50 pages
Accelerator Nordic AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Founded in 1993, Optovent is a Swedish medical company specialising in monitoring and diagnostic systems. The company produces equipment for situations where the observing of patients is vital, yet no...

January 2020 50 pages
Accel Transmatic Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Accel Transmatic Limited provides offshore services in product development, embedded systems, and application software development in India. Its Technologies division provides software development ser...

January 2020 50 pages
ACADIA Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs for the treatment of central nervous system disorders. Product Candid...

January 2020 50 pages
Abviva, Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Abviva, Inc., a biomedical corporation, focuses on the development and commercialization of breast cancer diagnostic and therapeutic products derived from a human biological secreted protein, Mammasta...

January 2020 50 pages
Abnova (Taiwan) Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Abnova (Taiwan) Corporation engages in biotechnology service industry in Taipei, Taiwan. It engages in the research and development of individual antibody reagent, individual antibody wafer or protein...

January 2020 50 pages
Ablynx NV Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Ablynx NV, a biopharmaceutical company, focuses on the discovery and development of Nanobodies, a class of therapeutic proteins based on single-domain antibody fragments for a range of serious and lif...

January 2020 50 pages
ABL Bio-Technologies Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

ABL Biotechnologies Limited engages in the identification and extraction of bio-chemicals, primarily from microbes in India. Its products are used as nutritional, cosmetic, pharmaceutical, and industr...

January 2020 50 pages
Abcam Plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Abcam plc, together with its subsidiaries, engages in developing, marketing, and selling antibodies and related products worldwide. The company primarily offers primary and secondary antibodies, isoty...

January 2020 50 pages
Abbott Laboratories (Pakistan) Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Abbott Laboratories (Pakistan) Limited, a healthcare company, engages in the manufacture, import, and marketing of pharmaceutical, nutritional, diagnostic, diabetes care, molecular, hospital, and cons...

January 2020 50 pages
Abbott Laboratories Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. The company’s segments include Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products...

January 2020 72 pages
Abbott India Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Abbott India Limited engages in the discovery, development, manufacture, and marketing of pharmaceutical, diagnostic, nutritional, and hospital products in India. The company offers its products in th...

January 2020 50 pages
AB Science S.A. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

AB Science S.A., a pharmaceutical company, engages in the discovery, development, and commercialization of protein kinase inhibitors for use in human and veterinary medicine in the United States and E...

January 2020 50 pages
Aastrom Biosciences, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Aastrom Biosciences, Inc., a development stage regenerative medicine company, focuses on the development of cell therapies to repair or regenerate damaged or diseased tissues. Clinical Development Pro...

January 2020 50 pages
Aarti Drugs Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Aarti Drugs Limited engages in the manufacture and sale of bulk drugs and its intermediates in India and internationally. It offers various active pharmaceutical ingredients in the therapeutic categor...

January 2020 50 pages
Aarey Drugs & Pharmaceuticals Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Aarey Drugs & Pharmaceuticals Limited manufactures, supplies, and exports pharmaceutical raw materials, chemicals, pharmaceuticals ingredients, active pharmaceutical ingredient drugs, food colours, an...

January 2020 50 pages
A.L. Industrier ASA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

A.L. Industrier ASA engages in the ownership, management, and rental of real estate properties in Oslo, Norway. Its property portfolio comprises office, manufacturing, and warehouse facilities. The co...

January 2020 50 pages
Advaxis Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Advaxis, Inc., a development stage biotechnology company, develops cancer vaccines that utilize multiple mechanisms of immunity. Products The company is developing a live Listeria vaccine technology u...

January 2020 50 pages
Adventrx Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

ADVENTRX Pharmaceuticals, Inc., a developmental stage biopharmaceutical company, engages in developing, in-licensing, and commercializing proprietary product candidates for the treatment of cancer. Pr...

January 2020 50 pages
Advik Laboratories Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis US$ 499.00

Advik Laboratories Limited engages in the manufacture and sale of pharmaceutical products in India. The company offers ethical and generic drugs in various formulations. Its generic product portfolio...

January 2020 50 pages